TD Asset Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Buy |
113,968
+91,600
| +410% | +$1.37M | ﹤0.01% | 975 |
|
|
2025
Q1 | $361K | Sell |
22,368
-42,600
| -66% | -$687K | ﹤0.01% | 1171 |
|
|
2024
Q4 | $1.51M | Buy |
64,968
+12,200
| +23% | +$284K | ﹤0.01% | 1064 |
|
|
2024
Q3 | $1.5M | Buy |
52,768
+17,600
| +50% | +$501K | ﹤0.01% | 1116 |
|
|
2024
Q2 | $827K | Sell |
35,168
-25,800
| -42% | -$607K | ﹤0.01% | 1195 |
|
|
2024
Q1 | $2.31M | Buy |
+60,968
| New | +$2.31M | ﹤0.01% | 973 |
|